BTCH30003 Biotechnology in Practice
University of Melbourne · Level 3 · 12.5 points · Runs in 2026: Semester 1.
- Final exam 50%
- About 3 class hours a week
- 20% group work
Is BTCH30003 hard?
BTCH30003: Easier. Makes it easier: Reviewers say it’s manageable (7 reviews).
What you learn
How biotech discoveries go from the lab to market, including intellectual property, regulation and funding.
After it you can
- Assess the commercial potential of a biotech
- Pitch the value of a new biotech product
- Weigh the ethical and social impacts
What you need first
None
Careers
Helps toward: Biochemist, Microbiologist, Zoologist, Laboratory scientist, Veterinarian, Biotechnologist
How it’s assessed
Projects 20%, Reports and essays 30%, Final exam 50%
Student reviews and ratings
Summarised from 7 students on StudentVIP (2018–2026)
- It is mostly about the biotech business: IP, regulation and financial analysis, with little lab science. Expect a commerce-style subject.
- Many found the lectures repetitive, loosely structured and dry. 2026 reviewers said the guidance on what matters was unclear.
- Workload looks low until the assessments arrive. The group video depends on teammates, and the investment report was marked harder.
- Reviewers say a high mark is quite reachable and the final exam is easy, but you need to stay engaged with the dry material.
A summary of public reviews, not scored here.
Taken this subject? Rate it anonymously (difficulty, workload, marking, would you recommend it) and leave a tip for next year's students. Rate BTCH30003
Quick answers
- When is BTCH30003 offered?
- Runs in 2026: Semester 1.
- What do I need before taking BTCH30003?
- No prerequisites.
- Does BTCH30003 have a final exam?
- Yes, the final exam is 50% of the mark. Assessment: Projects 20%, Reports and essays 30%, Final exam 50%.
- Is BTCH30003 hard?
- From 7 student reviews on StudentVIP: It is mostly about the biotech business: IP, regulation and financial analysis, with little lab science. Expect a commerce-style subject.
- What do students say about BTCH30003?
- It is mostly about the biotech business: IP, regulation and financial analysis, with little lab science. Expect a commerce-style subject. Many found the lectures repetitive, loosely structured and dry. 2026 reviewers said the guidance on what matters was unclear. Workload looks low until the assessments arrive. The group video depends on teammates, and the investment report was marked harder.
- How many class hours a week does BTCH30003 have?
- 3 h a week in class
- Can I take BTCH30003 as breadth?
- Yes, for: Bachelor of Arts, Bachelor of Commerce, Bachelor of Design, Bachelor of Fine Arts (Acting), Bachelor of Fine Arts (Animation), Bachelor of Fine Arts (Dance), Bachelor of Fine Arts (Film and Television), Bachelor of Fine Arts (Music Theatre), Bachelor of Fine Arts (Production), Bachelor of Fine Arts (Screenwriting), Bachelor of Fine Arts (Theatre), Bachelor of Fine Arts (Visual Art), Bachelor of Music.
- Can I rate BTCH30003?
- Yes. If you've taken it, rate it anonymously on this page (difficulty, workload, marking, would you recommend it) and leave a tip for next year's students. Averages show once 3 students have rated it; tips are checked before they appear.
Source: University of Melbourne Handbook 2026
Always confirm in the official Handbook.
PickMySubjects is a free, unofficial planner made by a UniMelb graduate.